MYO5B and heart failure: In contrast, control αMHC-Cretg/− mice showed no increased mortality compared with WT mice at the time when MYO5b-KO mice had already died due to cardiac failure (see Supplementary data online, Figure S4D) and only a mild decrease in cardiac function, as reported by others23 (see Supplementary data online, Table S6).